Jaguar Health, Inc. (JAGX)
4.78
+0.25
(+5.52%)
USD |
NASDAQ |
Oct 09, 16:00
4.85
+0.07
(+1.46%)
After-Hours: 20:00
Jaguar Health EPS Diluted (Quarterly) : -235.46 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -235.46 |
| March 31, 2026 | -204.00 |
| December 31, 2025 | -1746.00 |
| September 30, 2025 | -3296.74 |
| June 30, 2025 | -5384.08 |
| March 31, 2025 | -8766.70 |
| December 31, 2024 | -9855.43 |
| September 30, 2024 | -13802.78 |
| June 30, 2024 | -53026.71 |
| March 31, 2024 | -45738.00 |
| December 31, 2023 | -98728.88 |
| September 30, 2023 | -295336.1 |
| June 30, 2023 | -542674.1 |
| March 31, 2023 | -1.881M |
| December 31, 2022 | -2.701M |
| September 30, 2022 | -6.952M |
| June 30, 2022 | -6.942M |
| March 31, 2022 | -23.76M |
| December 31, 2021 | -16.75M |
| September 30, 2021 | -15.71M |
| June 30, 2021 | -18.56M |
| March 31, 2021 | -16.97M |
| December 31, 2020 | -17.34M |
| September 30, 2020 | -36.44M |
| Date | Value |
|---|---|
| June 30, 2020 | -78.59M |
| March 31, 2020 | -98.48M |
| December 31, 2019 | -26.03M |
| September 30, 2019 | -354.36M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | -0.9617 |
| December 31, 2017 | -3.570 |
| September 30, 2017 | 1.302 |
| June 30, 2017 | -2.233 |
| March 31, 2017 | -6.140 |
| December 31, 2016 | -5.209 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | -6.597 |
| March 31, 2016 | -7.964 |
| December 31, 2015 | -9.459 |
| September 30, 2015 | -6.781 |
| June 30, 2015 | -18.64 |
| March 31, 2015 | 0.00 |
| June 30, 2014 | -4.677 |
| March 31, 2014 | -4.453 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Omeros Corp. | 0.1476 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 2.268 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.80M |
| Revenue (Quarterly) | 1.225M |
| Total Expenses (Quarterly) | 13.91M |
| Enterprise Value | 11.49M |
| Gross Profit Margin (Quarterly) | -22.04% |
| Profit Margin (Quarterly) | -1.05K% |
| Earnings Yield | -114.7K% |
| Normalized Earnings Yield | -98511.67 |